Garbaisz Dávid, Boros András, Legeza Péter, Szeberin Zoltán
Városmajori Szív- és Érgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Városmajor u. 68., 1122.
Érsebészeti Tanszék, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.
Orv Hetil. 2018 Apr;159(13):520-525. doi: 10.1556/650.2018.30968.
Iliac artery aneurysms make up 2% of all aneurysms. There are only a few data available on the results of surgical treatment, therefore the optimal treatment is unclear. Our objective was the retrospective analysis of the perioperative morbidity and mortality of patients who underwent iliac artery surgery as well as the comparison of elective open surgery and endovascular iliac aneurysm repair (EVIAR).
Retrospective analysis of patients who underwent surgery for iliac artery aneurysm between 1 January 2005 and 31 December 2014.
During the 10-year period, 62 patients with a mean age of 68.9 years underwent elective surgery for iliac artery aneurysm (54 males, 87.1%). In 10 cases acute surgery was performed due to aneurysm ruptures (13.9%), 3 patients died within the perioperative period (30%). Regarding anatomical localisation, aneurysm developed mostly on the common iliac artery (80.6%). As an elective surgery, 35 patients (56.5%) underwent open surgery, 25 (40.3%) underwent EVIAR and other endovascular interventions were performed in 2 cases (3.2%). Postoperative complications (1 patient [4.0%] vs. 17 patients [48.5%]; p<0.001) and intensive care treatment (29 patients [82.8%] vs. 2 patients [8.0%]; p<0.001) were significantly rarer after EVIAR than after open surgery. Furthermore, EVIAR resulted in considerably shorter postoperative hospital stays (4.7 ± 2.3 days vs. 11.8 ± 12.2 days; p = 0.006) and significantly less blood transfusion demand (1 patient [4.0%] vs. 26 patients [74.2%]; p<0.001). There were no significant differences regarding long-term survival rates between EVIAR and open surgery (81.4% vs. 71.4%; p = 0.95).
In case of the surgical treatment of iliac artery aneurysms, owing to the lower complication rates and shorter postoperative length of stay, EVIAR is primarily recommended. Orv Hetil. 2018; 159(13): 520-525.
髂动脉瘤占所有动脉瘤的2%。关于手术治疗结果的可用数据很少,因此最佳治疗方法尚不清楚。我们的目的是对接受髂动脉手术患者的围手术期发病率和死亡率进行回顾性分析,并比较择期开放手术和髂动脉瘤腔内修复术(EVIAR)。
对2005年1月1日至2014年12月31日期间接受髂动脉瘤手术的患者进行回顾性分析。
在这10年期间,62例平均年龄为68.9岁的患者接受了髂动脉瘤择期手术(54例男性,占87.1%)。10例(13.9%)因动脉瘤破裂进行了急诊手术,3例患者(30%)在围手术期死亡。关于解剖定位,动脉瘤大多发生在髂总动脉(80.6%)。作为择期手术,35例患者(56.5%)接受了开放手术,25例(40.3%)接受了EVIAR,2例(3.2%)进行了其他血管腔内干预。EVIAR术后并发症(1例[4.0%]对17例[48.5%];p<0.001)和重症监护治疗(29例[82.8%]对2例[8.0%];p<0.001)明显少于开放手术后。此外,EVIAR术后住院时间明显缩短(4.7±2.3天对11.8±12.2天;p = 0.006),输血需求明显减少(1例[4.0%]对26例[74.2%];p<0.001)。EVIAR和开放手术的长期生存率无显著差异(81.4%对71.4%;p = 0.95)。
在髂动脉瘤的手术治疗中,由于并发症发生率较低且术后住院时间较短,主要推荐EVIAR。《匈牙利医学周报》。2018年;159(13): 520 - 525。